Lilly Expands Drug Discovery Efforts in Singapore
Broader Research Focus Will Leverage Local and Regional Talent
28-Mar-2007 -
Eli Lilly and Company announced a USD $150 million expansion, over the next five years, of its state-of-the-art drug discovery research activities at the Lilly Centre for Systems Biology (LSB). The project, a partnership with the Singapore Economic Development Board (EDB), will take advantage of ...
adult stem cells
biomarker
biomarkers
+9